Bisphosphonates: Mechanism of Action in Osteoporosis Treatment

Osteoporosis associated with colourful factors analogous as menopause and aging is the most common bred-in-thebone metabolic bone ailment characterized by increased bone fragility. Although it occurs in all days, genders, and races, it's most common in Caucasians (white race), the aging, and women. With a growing population and a longer life time, osteoporosis is inchmeal getting a global epidemic. It's estimated that farther than 200 million people presently suffer from osteoporosis. According to the last statistics from the Multinational Osteoporosis Foundation, 1 in 3 women over 50 and 1 in 5 men will suffer osteoporotic fractures in their life. Each break is a sign of another to come. Osteoporosis has no clinical images until a fracture occurs. Fractures engender significant morbidity; especially in men, they can engender death. Either, osteoporosis entails a reduction in the quality of life, a longer life expectance for people with disabilities and a great moneyspinning burden for the health insurance systems of the countries responsible for the care of these cases.

Author(s): Leah Kuhn

Abstract | Full-Text | PDF

Share This Article